Funded PhD: Irish ABO and Coagulation strategic partnership

This programme will define the biological mechanisms through which ABO blood group influences blood coagulation and thrombosis.

  • Principal investigator(s) Dr Jamie O'Sullivan, Prof. James O'Donnell
  • Research theme Vascular Biology

Although ABO blood group has been known to affect the risks of bleeding and thrombosis for many years, critically the mechanisms underpinning this relationship remain poorly understood.

By bringing together investigators from leading haemostasis research groups in RCSI and blood transfusion medicine experts from the IBTS, the iABC Strategic Partnership will adopt a unique state-of-the-art research programme to characterize the biological mechanisms through which ABO blood group influences blood coagulation.

The programme will therefore address clinically important research questions that have key implications for transfusion medicine practice.

Given the huge morbidity and mortality associated with bleeding, defining the mechanisms though which ABO affects coagulation is of direct clinical importance. Our innovative plan of investigation will also provide novel insights into the relationship between ABO blood group, heavy menstrual bleeding and iron deficiency in young women.

This research project is fully funded via a strategic partnership programme involving the Irish Blood Transfusion Service (IBTS) and Research Ireland.

Tenure: Four years

Start date: 1 September 2026

Specification

Minimum requirements

  • The successful applicant will have a degree (honours bachelors or master's) in a biological sciences subject, such as cell biology, biochemistry, molecular biology, genetics, pharmacology or physiology.

Desirable candidate specifications

  • A strong interest in haematology and vascular biology research.
  • Good organisational and communication skills.
  • Ability to work both independently and as part of a multidisciplinary team.

Application process

Please apply for the research project through the link below.

Applicants must complete the application form:

Apply now

Application deadline: 31 July 2026

Shortlisting: Early August 2026

Please note:

  •  It is the candidate’s responsibility to ensure the application form is completed in full and on time – late and/or incomplete applications will not normally be assessed.
  • Unfortunately, we are unable to provide individual feedback to applicants.
  • Shortlisted candidates will be invited for interview (applicants may attend a virtual interview)
  • At this stage only successful candidates will be contacted to submit, CV, transcripts and other relevant documentation.
  • Only their referees will also be contacted at this stage for a reference.